| abstract |
In the present application, there is provided a pharmaceutical composition for lowering the serum uric acid level of a subject to treat a condition associated with elevated serum uric acid levels, comprising administering a composition comprising a first uric acid-lowering agent and a second uric acid-lowering agent , A method and a kit. In some embodiments, the first urate salt-lowering agent is (-) - halophenate, (-) - haloperbenzoic acid, or a pharmaceutically acceptable salt thereof. In some embodiments, the second uric acid-lowering agent is a uric acid production inhibitor, a uric acid excretion promoter, a uricase, or a pharmaceutically acceptable salt thereof. |